NCT07490132Recruiting

Endoscopic Retrograde Cholangiopancreatography

Methodist Health System

Start Date

2/1/2026

Completion Date

2/1/2028

Summary

The risk of post-endoscopic retrograde cholangiopancreatography(ERCP) pancreatitis(PEP) is influenced by patient and procedure-related factors. Strategies to decrease PEP(Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis) are of great importance.

Detailed Description

The primary objective of this study is to provide a mechanism to store the following information about patients undergoing ERCPs at Methodist Dallas Medical Center. This registry will be permissive of quality improvement and research studies.

Eligibility Criteria

Age Range: 15 years to No maximum

Inclusion Criteria: Patients \>15 years Included in MDI's Registry Underwent ERCP between January 1, 2000 through December 31, 2025 Exclusion Criteria: Patients \<15 years Patients in which cannulation was via a surgical anastomosis Patients in which cannulation was not attempted due to gastric outlet obstruction, the main papilla not found, or the minor papilla was not found will be excluded.

Interventions

OTHER

Patients undergoing ERCPs at Methodist Dallas Medical Center

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Gastro-Intestinal Disorder

Locations

Methodist Dallas Medical Center- Clinical Research Institute

Dallas, Texas 75203

United States